SCHEMBL9040548

SCHEMBL9040548

BrCCOC1CCCc2nc3ccccc3c(NCc3ccccc3)c21

nearest known ligand 0.65

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.53
MEN1 O00255 1/20 0.53
HTT P42858 1/20 0.53
KMT2A Q03164 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10870026 0.82 KDM4E (0.54) KDM4EMEN1HTTKMT2A
SCHEMBL9041102 0.80 CYP1A2 (0.58)
Suronacrine SCHEMBL975421 0.79
SCHEMBL9039716 0.73 ACHE (0.51)
Suronacrine SCHEMBL635351 0.73
SCHEMBL9875337 0.73
SCHEMBL9876171 0.72
SCHEMBL9874956 0.72
SCHEMBL9875894 0.72
SCHEMBL9875908 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5112829-A Intermediates for Cognition Activators HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-05-12 US claimed
EP-0430114-B1 Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds, a process and intermediates for their preparation and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1996-02-07 EP disclosed
US-5112829-A Intermediates for Cognition Activators HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-05-12 US disclosed
EP-0430114-A2 Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds, a process and intermediates for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-06-05 EP disclosed
US-4994452-A Memory disfunction HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1991-02-19 US disclosed